Physician profile

Stacy Royer

Family · Dripping Springs, TX

NPI 1053911149

$5,054.37

in general payments reported to CMS, 2019-2025

32 companies · $1,437 in 2025

The $1,437 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,057.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $743.25 2021-2025
Astrazeneca Pharmaceuticals LP $593.41 2021-2025 Farxiga, Airsupra, Breztri
Pfizer INC. $517.01 2023-2025
Lilly USA, LLC $439.47 2021-2025 Mounjaro, Zepbound, Jardiance
Novo Nordisk INC $431.11 2022-2025 Ozempic, Rybelsus, Wegovy
Glaxosmithkline, LLC. $410.49 2021-2025 Trelegy Ellipta, Arexvy, Shingrix
Boehringer Ingelheim Pharmaceuticals, INC. $283.79 2022-2025 Jardiance, Synjardy
Bausch Health US, LLC $201.25 2022-2025 Aplenzin, Wellbutrin
Exact Sciences Corporation $150.78 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Amgen INC. $134.59 2022-2025 Repatha, Otezla, Repatha
Bayer Healthcare Pharmaceuticals INC. $133.45 2022-2024
Dexcom, INC. $123.95 2024-2025 Dexcom G6 Transmitter
Eisai INC. $113.65 2021
Cmp Pharma, INC. $83.78 2022
Noven Therapeutics, LLC $83.44 2024 Xelstrym
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $79.84 2023-2024 Xarelto
Medtronic, INC. $70.04 2024-2025 Synchromedii, Intellis Adaptivestim
Xeris Pharmaceuticals, INC. $61.90 2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $55.34 2022-2023 Xifaxan
Currax Pharmaceuticals LLC $44.78 2022-2023 Contrave, Nexlizet, Nexletol
Astellas Pharma US INC $44.33 2024 Veozah
Amarin Pharma, INC. $37.61 2021
Takeda Pharmaceuticals U.S.A., INC. $36.07 2021-2022
Biohaven Pharmaceutical Holding Company LTD. $33.83 2022
Merck Sharp & Dohme LLC $32.63 2024 Gardasil 9, Gardasil, Capvaxive
Novartis Pharmaceuticals Corporation $24.18 2023
Cranial Technologies, INC $20.53 2023 Doc Band
Tolmar, INC. $15.99 2025 Jatenzo
Esperion Therapeutics, INC. $15.79 2023 Nexletol
Si-Bone, INC. $15.46 2021
Irhythm Technologies, INC. $12.70 2023 Zio Xt Patch
Genentech USA, INC. $9.93 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stacy Royer

$5,054.37

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $1,437 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/11188961/stacy-royer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.